# Multi-modal Predictive Models of Diabetes Progression

**Authors:** Ramin Ramazi, Christine Perndorfer, Emily Soriano, Jean-Philippe, Laurenceau, Rahmatollah Beheshti

arXiv: 1907.12175 · 2019-07-30

## TL;DR

This paper presents a multi-modal deep learning model using wearable device data and clinical information to predict key biomarkers of type 2 diabetes progression over one year.

## Contribution

It introduces a novel wide and deep neural network with LSTM components that integrates diverse data sources for T2D biomarker prediction.

## Key findings

- Achieved low RMSE for biomarker predictions
- Demonstrated improved accuracy over existing models
- Integrated multi-modal data effectively

## Abstract

With the increasing availability of wearable devices, continuous monitoring of individuals' physiological and behavioral patterns has become significantly more accessible. Access to these continuous patterns about individuals' statuses offers an unprecedented opportunity for studying complex diseases and health conditions such as type 2 diabetes (T2D). T2D is a widely common chronic disease that its roots and progression patterns are not fully understood. Predicting the progression of T2D can inform timely and more effective interventions to prevent or manage the disease. In this study, we have used a dataset related to 63 patients with T2D that includes the data from two different types of wearable devices worn by the patients: continuous glucose monitoring (CGM) devices and activity trackers (ActiGraphs). Using this dataset, we created a model for predicting the levels of four major biomarkers related to T2D after a one-year period. We developed a wide and deep neural network and used the data from the demographic information, lab tests, and wearable sensors to create the model. The deep part of our method was developed based on the long short-term memory (LSTM) structure to process the time-series dataset collected by the wearables. In predicting the patterns of the four biomarkers, we have obtained a root mean square error of 1.67% for HBA1c, 6.22 mg/dl for HDL cholesterol, 10.46 mg/dl for LDL cholesterol, and 18.38 mg/dl for Triglyceride. Compared to existing models for studying T2D, our model offers a more comprehensive tool for combining a large variety of factors that contribute to the disease.

---
Source: https://tomesphere.com/paper/1907.12175